Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -1% | 8.2% | 15.1% |
| Success rate | 40% | 68% | 82% |
| Transactions |
20
75% Buy
|
34
71% Buy
|
47
69% Buy
|
| Average return | 138% |
|---|---|
| Success rate | 73% |
| Average holding period | 220 |
| Transactions | 28 |
| Position | Company | Period |
|---|---|---|
| Chief Financial Officer | Aimmune Therapeutics Inc | Dec. 1, 2019 - |
| Independent Director | Cerus Corp | Oct. 9, 2018 - |
| Chief Financial Officer | Aimmune Therapeutics Inc | April 13, 2017 - Dec. 1, 2019 |
| Independent Director | Corium International Inc | April 1, 2015 - Nov. 26, 2018 |
| Chief Financial Officer, Executive Vice President - Corporate Development and Finance, Corporate Secretary | Sunesis Pharmaceuticals Inc | Jan. 1, 2016 - April 7, 2017 |
| Independent Director | Microbot Medical Inc | March 1, 2004 - Nov. 28, 2016 |
| Chief Financial Officer, Executive Vice President - Corporate Development and Finance | Sunesis Pharmaceuticals Inc | Feb. 2, 2012 - Jan. 1, 2016 |
| Chief Financial Officer, Senior Vice President - Corporate Development and Finance | Sunesis Pharmaceuticals Inc | Feb. 1, 2007 - Feb. 2, 2012 |
Search